Evaluation of Rupture of Galenic Practices at Home in a Population Aged 65 or Older

NCT ID: NCT03681899

Last Updated: 2020-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

289 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-18

Study Completion Date

2019-12-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Elderly people frequently take several medications and are exposed to iatrogenic risks.

The oral route is the preferred route of administration. The effectiveness and the safety of the drugs depend in particular on the modes of administration (frequency of the intake, respect of the doses and the galenic ...).

However, these modalities are very little known concerning the treatments intake at home in the elderly population.

In a health facility welcoming geriatric patients, the rupture of galenic is frequent and favored by swallowing disorders, dependence, the increase in age, the presence of cognitive disorders or psycho-behavioral disorders.

The consequences of the rupture of galenic are numerous, concern the patients but also the caregivers who administer the treatments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary objective :

\- Estimate the rupture of galenic prevalence of at least one molecule in a population of subjects aged 65 years or over living at home and taking at least one oral drug for 2 weeks or more.

Secondary objectives:

* Identify the drug classes most frequently involved in the rupture of galenic in a population of subjects aged 65 years of age or over at home;
* Identify the actors of the drug administration in a population of subjects aged 65 years of or over at home;
* To determine the medical and sociodemographic factors associated with the rupture of galenic in a population of subjects aged 65 years or over at home;
* To determine the modalities of rupture of galenic in a population of subjects aged 65 or over at home.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Geriatric Assessment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects aged of 65 years or older

Subjects aged of 65 years or older, taking at least one oral medication for two weeks or more.

Questionnaires

Intervention Type OTHER

* Socio-demographic data (age, sex, place of residence, and family status, last occupation, existence or not of a primary caregiver (family and / or professional));
* Medical and surgical history (Charlson Comorbidity Scale);
* Assessment of oral/dental condition
* Record of drug treatments (number of oral medications per day, therapeutic class, number of daily intakes);
* Oral treatments intake modalities (galenic breakdown of one or more drugs, usual or occasional, modalities of rupture, person responsible for the drugs, mixing with food / drink);
* Autonomy evaluation (Lawton and Katz scales);
* Mobility assessment (anamnestic evaluation);
* Evaluation of Thyme (GDS 4 items);
* Psycho-behavioral disorders,
* Assessment of swallowing (presence of a diagnosis of dysphagia or suspicion based on anamnestic data).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

* Socio-demographic data (age, sex, place of residence, and family status, last occupation, existence or not of a primary caregiver (family and / or professional));
* Medical and surgical history (Charlson Comorbidity Scale);
* Assessment of oral/dental condition
* Record of drug treatments (number of oral medications per day, therapeutic class, number of daily intakes);
* Oral treatments intake modalities (galenic breakdown of one or more drugs, usual or occasional, modalities of rupture, person responsible for the drugs, mixing with food / drink);
* Autonomy evaluation (Lawton and Katz scales);
* Mobility assessment (anamnestic evaluation);
* Evaluation of Thyme (GDS 4 items);
* Psycho-behavioral disorders,
* Assessment of swallowing (presence of a diagnosis of dysphagia or suspicion based on anamnestic data).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects aged 65 or over;
* Patient taking at least one oral medication for two weeks or more;
* Patient affiliated to a social security scheme;
* Patient who has agreed to reply to the questionnaire or, in case of inability to agree, agreement obtained from the caregiver or guardian/curator.

Exclusion Criteria

* Patient unable to answer questionnaires and without a referent caregiver capable of reply ;
* Patient having changed residence for two weeks or less;
* Patient residing in a residential care facility for dependent elderly people.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Center of Martinique

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Martinique

Fort-de-France, Martinique, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18_RIPH3-07

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Aging and Frailty Study
NCT05268991 COMPLETED
Food at Home Study
NCT06286514 RECRUITING